Publicaciones (106) Publicaciones de MANUEL LIZASOAÍN HERNÁNDEZ

2023

  1. Bacteremia in Patients with Solid Organ Cancer: Insights into Epidemiology and Antibiotic Consumption

    Cancers, Vol. 15, Núm. 23

  2. Cytomegalovirus reactivation in patients with immune-mediated gastritis

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 5, pp. 298-300

  3. Disparities between Latinx migrants and Spanish natives in COVID-19 outcome in Madrid

    Pathogens and Global Health, Vol. 117, Núm. 6, pp. 590-595

  4. Enhancing screening adherence for strongyloides infection in latinx inpatients with COVID-19: a local protocol implementation study

    Pathogens and Global Health

  5. Nirmatrelvir/ritonavir for the treatment of immunocompromised adult patients with early-stage symptomatic COVID-19: A real-life experience

    Journal of Medical Virology, Vol. 95, Núm. 9

  6. Prevalence of Chagas disease in Latin American pregnant women in Madrid, Spain: A multicentre cross-sectional study from 2011 to 2016

    Tropical Medicine and International Health, Vol. 28, Núm. 12, pp. 912-922

  7. Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 12, pp. 1485-1497

2022

  1. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem

    Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524

  2. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

    International Journal of Infectious Diseases, Vol. 117, pp. 56-64

  3. Derivation of a score to predict infection due to multidrug-resistant Pseudomonas aeruginosa: a tool for guiding empirical antibiotic treatment

    Journal of Global Antimicrobial Resistance, Vol. 29, pp. 215-221

  4. Effectiveness of ceftazidime-avibactam for the treatment of infections due to Pseudomonas aeruginosa

    International Journal of Antimicrobial Agents, Vol. 59, Núm. 2

  5. Higher mortality of hospitalized haematologic patients with COVID-19 compared to non-haematologic is driven by thrombotic complications and development of ARDS: An age-matched cohorts study

    Clinical Infection in Practice, Vol. 13

  6. Prognostic factors of OXA-48 carbapenemase-producing Klebsiella pneumoniae infection in a tertiary-care Spanish hospital: A retrospective single-center cohort study

    International Journal of Infectious Diseases, Vol. 119, pp. 59-68

  7. Risk Factors and Outcomes for Multidrug Resistant Pseudomonas aeruginosa Infection in Immunocompromised Patients

    Antibiotics, Vol. 11, Núm. 11

  8. Time of incubation of agar-plate culture for the diagnosis of Strongyloides stercoralis infection

    Acta Tropica, Vol. 226

2021

  1. Eradication of staphylococcus aureus post-sternotomy mediastinitis following the implementation of universal preoperative nasal decontamination with mupirocin: An interrupted time-series analysis

    Clinical Infectious Diseases, Vol. 73, Núm. 9, pp. 1685-1692

  2. Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study

    Journal of Medical Virology, Vol. 93, Núm. 2, pp. 831-842

2020

  1. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies

    European Journal of Haematology, Vol. 105, Núm. 5, pp. 597-607

  2. Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4

  3. Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Network for Research in Infectious Diseases (REIPI) and the Spanish Society of Haematology and Haemotherapy (SEHH) on the management of febrile neutropenia in patients with hematological malignancies

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 174-181